BiotechTube

0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)

Phase 1Completed
0 watching 0 views this week💤 Quiet
32
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Menopause

Conditions

Menopause, Healthy

Trial Timeline

Mar 1, 2005 → Jun 1, 2005

NCT ID
NCT01477632

About 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)

0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) is a phase 1 stage product being developed by Novo Nordisk for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT01477632. Target conditions include Menopause, Healthy.

Hype Score Breakdown

Clinical
10
Activity
5
Company
9
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01477632Phase 1Completed

Competing Products

20 competing products in Menopause

See all competitors
ProductCompanyStageHype Score
atomoxetine + placeboEli LillyPre-clinical
23
Fezolinetant + PlaceboAstellas PharmaPhase 2
52
CetrorelixShionogiPre-clinical
23
Teriparatide (PTH 1-34)Eli LillyPhase 2/3
65
Eszopiclone + PlaceboSumitomo PharmaPre-clinical
23
Comparator: placebo + Comparator: EstraceMerckPhase 1
33
esmirtazapine + PlaceboMerckPhase 3
77
Marketed low dose hormone replacement therapyNovo NordiskPre-clinical
22
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)Novo NordiskPre-clinical
22
1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)Novo NordiskApproved
84
estradiol, 10 mcg + estradiol, 25 mcg + placeboNovo NordiskPhase 3
76
estradiol, 25 mcgNovo NordiskPre-clinical
22
estradiol, 10 mcgNovo NordiskPhase 3
76
estradiol, 10 mcg + estradiol, 25 mcgNovo NordiskPhase 1
32
estradiol, 10 mcgNovo NordiskPhase 3
76
2 mg estradiol / 1 mg norethisterone acetate (NETA)Novo NordiskPhase 1
32
estradiol, 25 mcgNovo NordiskPhase 3
76
estradiol, 25 mcgNovo NordiskPhase 3
76
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placeboNovo NordiskPhase 3
76
estradiol, 25 mcg + estradiol, 25 mcgNovo NordiskPhase 1
32

Other Products from Novo Nordisk

Liraglutide 3.0mg + Placebo Oral Tablet + Phentermine 15 MGApproved
84
Liraglutide + SalineApproved
84
Hydrocortisone + PlaceboApproved
84
biphasic insulin aspart + insulin aspartApproved
84
Semaglutide, 1.34 mg/mL + Empagliflozin 25 MGApproved
84